Kelly Paulk, MD
Pain Medicine · Kenner, LANPI 1083034557
Payments from drug & device makers
What this record shows
17 manufacturers reported payments, led by Boston Scientific at 34.5% of the total. Reporting peaked in 2024 at $3,283 and has fallen 78.7% since, to $700 in 2025.
Across 82 payments — averaging $77.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Stryker$1K
- Nevro Corp.$915
- SPR Therapeutics, Inc$679
- Medtronic$419
- Avanos Medical$289
- plus $513 from 11 others
What the payments were for
- Travel & lodging$3,14749%
- Food & beverage$3,21151%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 18 | $2,190 |
| Stryker | 12 | $1,352 |
| Nevro Corp. | 13 | $915 |
| SPR Therapeutics, Inc | 6 | $679 |
| Medtronic(2 entities) | 9 | $419 |
| Avanos Medical | 3 | $289 |
| Amgen | 6 | $209 |
| Abbott | 3 | $54 |
| Saluda Medical Americas, Inc. | 2 | $42 |
| Vertex | 2 | $37 |
| Bioventus LLC | 2 | $33 |
| Merck | 1 | $30 |
| Vertiflex, Inc. | 1 | $27 |
| Pfizer | 1 | $25 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| Ipsen Biopharmaceuticals, Inc | 1 | $19 |
| Averitas Pharma Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,358 in reported general payments places this provider in the 65th percentile of 97 pain medicine providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 341 | $4,861 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 211 | $3,187 |
| Gabapentin | 192 | $2,620 |
| Duloxetine Hcl | 215 | $2,404 |
| Baclofen | 102 | $1,103 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 50 | $933 |
| Tizanidine Hcl | 105 | $810 |
| Diclofenac Sodium | 17 | $660 |
| Etodolac | 11 | $405 |
| Celecoxib | 28 | $395 |
| Oxycodone Hcl | 23 | $364 |
| Amitriptyline Hcl | 48 | $287 |
| Tramadol Hcl | 62 | $282 |
| Nortriptyline Hcl | 27 | $91 |
| Methocarbamol | 15 | $74 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Kenner
- Thomas MyersMandeville$118K
- Alan KayeNew Orleans$76K
- Derrick DeanTerrytown$68K
- Hazem EissaNew Orleans$50K
- Robert OwensNew Orleans$47K
- Gassan ChaibanLake Charles$30K
- Yashar EshraghiNew Orleans$22K
- Prathima AnandiShreveport$19K
- Jason GremillionBaton Rouge$19K
- Eric StockwellMetairie$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.